2023 · Frontiers in medicine · open access
Development and validation of method for analysis of favipiravir and remdesivir in volumetric absorptive microsampling with ultra high-performance liquid chromatography-tandem mass spectrophotometry
Harahap et al.
The finding, in our words
Researchers developed and validated a UHPLC-MS/MS method for simultaneous quantification of favipiravir and remdesivir from VAMS blood samples, meeting FDA and EMA validation criteria. The method uses simple protein precipitation and supports therapeutic drug monitoring of COVID-19 antivirals in settings where small sample volumes and simplified processing are advantageous.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.